Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Teva Commences Launch Of Irbesartan And Irbesartan-hydrochlorothiazide Tablets

RELATED NEWS
Trade TEVA now with 

Generic drugmaker Teva Pharmaceutical Industries Ltd. (TEVA: Quote) Monday said it has commenced commercial launch of both irbesartan and irbesartan-hydrochlorothiazide tablets, the company's generic versions of Sanofi Aventis' high blood pressure treatments, Avapro and Avalide tablets.

The brand products had annual sales of around $464 million and $124 million, respectively, in the U.S., based on IMS sales data.

As the first company to file Abbreviated New Drug Applications containing paragraph IV certifications for both of these products, Teva has been awarded a 180-day period of marketing exclusivity.

Click here to receive FREE breaking news email alerts for Teva Pharmaceutical Industries Limited and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Google and Microsoft are opposing a petition by hoteliers such as Marriott International the right to block personal Wi-Fi on their premises. Elon Musk, the CEO of electric car maker Tesla Motors Inc (TSLA), on Christmas announced an upcoming upgrade for Tesla Roadster that will improve its mile-range to about 400 miles. "Roadster upgrade will enable non-stop travel from LS to SF -- almost 400 mile range. Details tmrw. Merry Christmas!,"... United Parcel Service Inc. (UPS) said Friday that it expects consumers will ship more than 800,000 packages back to retailers and merchants on January 6, 2015, or the UPS National Returns Day. By the end of the first full week in January, the package delivery giant expects to transport 4 million return...
comments powered by Disqus